SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-19-018617
Filing Date
2019-09-23
Accepted
2019-09-23 08:12:20
Documents
12
Effectiveness Date
2019-09-23

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS defa14a092019_amagpharma.htm DEFA14A 102190
2 GRAPHIC eximg_001.jpg GRAPHIC 18399
3 GRAPHIC eximg_002.jpg GRAPHIC 44136
4 GRAPHIC eximg_003.jpg GRAPHIC 861
5 GRAPHIC eximg_004.jpg GRAPHIC 869
6 GRAPHIC eximg_005.jpg GRAPHIC 833
7 GRAPHIC eximg_006.jpg GRAPHIC 869
8 GRAPHIC eximg_008.jpg GRAPHIC 54745
9 GRAPHIC eximg_009.jpg GRAPHIC 4174
10 GRAPHIC eximg_010.jpg GRAPHIC 4586
11 GRAPHIC eximg_011.jpg GRAPHIC 3182
12 GRAPHIC eximg_012.jpg GRAPHIC 13351
  Complete submission text file 0001213900-19-018617.txt   305944
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-10865 | Film No.: 191106283
SIC: 2834 Pharmaceutical Preparations